You Ling, Tan Lun, Liu Lei, Shen Rufei, Chaugai Sandip, Wang Dao Wen, Cui Wei
Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Department of Internal Medicine and Institute of Hypertension, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Mol Genet Genomics. 2016 Feb;291(1):121-8. doi: 10.1007/s00438-015-1092-9. Epub 2015 Jul 19.
Genome-wide association studies of coronary artery disease (CAD) have recently identified a new susceptibility locus, ADAMTS7, in subjects of European ancestry. However, the significance of this locus in Chinese populations has not been identified. Therefore, this study was designed to evaluate the effect of rs3825807, a non-synonymous variant in the prodomain of the ADAMTS7 protease, on CAD risk and atherosclerosis severity in a Chinese population. We performed genetic association analyses in two independent case-control cohorts, which included a total of 8154 participants. Additionally, the association between the ADAMTS7 rs3825807 genotype and the proportion of CAD patients with 3- and 1-vessel disease was tested. We found that ADAMTS7 rs3825807 was associated with susceptibility to CAD in a Chinese population [odds ratio (OR) = 1.15, 95 % confidence interval (CI) = 1.05-1.26, P = 0.002]. The association remained significant after adjusting for clinical covariates (adjusted OR = 1.12, 95 % CI = 1.02-1.24, P = 0.02). Among 3741 angiographically documented CAD patients, the rs3825807 risk allele showed a significant association with disease severity (P = 0.04, trend P = 0.02). Additionally, 3-vessel disease demonstrated a strong and direct association with ADAMTS7 rs3825807 gene dosage (P = 0.02). Overall, our findings indicate that the significant associations observed between this coding variant in ADAMTS7 and the risk of CAD development are cross-ethnic, and the gene dosage is consistent with the degree of coronary atheromatous burden.
冠心病(CAD)的全基因组关联研究最近在欧洲血统人群中发现了一个新的易感基因座ADAMTS7。然而,该基因座在中国人群中的意义尚未明确。因此,本研究旨在评估ADAMTS7蛋白酶前结构域中的一个非同义变体rs3825807对中国人群CAD风险和动脉粥样硬化严重程度的影响。我们在两个独立的病例对照队列中进行了基因关联分析,共纳入8154名参与者。此外,还测试了ADAMTS7 rs3825807基因型与3支血管病变和单支血管病变CAD患者比例之间的关联。我们发现,ADAMTS7 rs3825807与中国人群的CAD易感性相关[比值比(OR)=1.15,95%置信区间(CI)=1.05 - 1.26,P = 0.002]。在调整临床协变量后,该关联仍然显著(调整后OR = 1.12,95% CI = 1.02 - 1.24,P = 0.02)。在3741名经血管造影证实的CAD患者中,rs3825807风险等位基因与疾病严重程度显著相关(P = 0.04,趋势P = 0.02)。此外,3支血管病变与ADAMTS7 rs3825807基因剂量呈强烈的直接关联(P = 0.02)。总体而言,我们的研究结果表明,ADAMTS7中这个编码变体与CAD发生风险之间的显著关联具有跨种族性,并且基因剂量与冠状动脉粥样硬化负担程度一致。